Encouraging report for Parkinson’s vaccine

The Michael J. Fox Foundation and Affiris have just reported the first phase I trial data for a novel vaccine targeting alpha synuclein. Click on the link below to read more about this from an article I wrote for the conversation:

https://theconversation.com/first-stage-trial-of-new-vaccine-offers-glimmer-of-hope-to-parkinsons-sufferers-30012

 

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s